Heat Shock Proteins and Ovarian Cancer: Important Roles and Therapeutic Opportunities
Ovarian cancer is a serious cause of death in gynecological oncology. Delayed diagnosis and poor survival rates associated with late stages of the disease are major obstacles against treatment efforts. Heat shock proteins (HSPs) are stress responsive molecules known to be crucial in many cancer type...
Main Authors: | Abdullah Hoter, Hassan Y. Naim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/9/1389 |
Similar Items
-
The Multiple Roles and Therapeutic Potential of Molecular Chaperones in Prostate Cancer
by: Abdullah Hoter, et al.
Published: (2019-08-01) -
Impaired Heat Shock Protein Expression in Activated T Cells in B-Cell Lymphoma
by: Zarema Albakova, et al.
Published: (2022-10-01) -
Targeting Heat Shock Proteins in Malignant Brain Tumors: From Basic Research to Clinical Trials
by: Aisha Babi, et al.
Published: (2022-11-01) -
Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors
by: Ana J. Rodrigues Moita, et al.
Published: (2020-11-01) -
Targeting Heat Shock Protein 27 and Fatty Acid Oxidation Augments Cisplatin Treatment in Cisplatin-Resistant Ovarian Cancer Cell Lines
by: James Patrick Heiserman, et al.
Published: (2023-08-01)